p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3445-3453

  Geisler, Stacy A ^a   Olshan, Andrew F ^a,b   Weissler, Mark C ^b   Cai, Jainwen ^a   Funkhouser, William K ^b   Smith, Joanna ^a   Vick, Katie ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53; PROTEIN P16;

AGED; ARTICLE; BIOSYNTHESIS; COHORT ANALYSIS; FEMALE; HEAD AND NECK TUMOR; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; TIME; ADULT; ALCOHOL CONSUMPTION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DEATH; DISEASE MARKER; FOLLOW UP; HEAD AND NECK CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA;

AGED; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036847705     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Ries, L., Eisner, M., Kosary, C., Hankey, B., Miller, B., Clegg, L., and Edwards, B. In: National Cancer Institute (ed.), SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: 2001
2. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res., 56: 2488-2492, 1996
3. Liggett, W. H., Jr., Sewell, D. A., Rocco, J., Ahrendt, S. A., Koch, W., and Sidransky, D. p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56: 4119-4123, 1996
4. Lai, S., and El-Naggar, A. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinoma. Lab. Investig., 79: 255-260, 1999
5. Zhang, Y., Xiong, Y., and Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92: 725-734, 1998
6. Gonzalez, M. V., Pello, M. F., Lopez-Larrea, C., Suarez, C., Menendez, M. J., and Coto, E. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J. Clin. Pathol., 50: 509-512, 1997
7. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996
8. El-Naggar, A., Lai, S., Clayman, G., Lee, J., Luna, M., Goepfert, H., and Batsakis, J. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am. J. Pathol., 151: 1767-1774, 1997
9. INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin. Cancer Res., 5: 2810-2819, 1999
10. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993
11. Shin, D. M., Lee, J. S., Lippman, S. M., Lee, J. J., Tu, Z. N., Choi, G., Heyne, K., Shin, H. J., Ro, J. Y., Goepfert, H., Hong, W. K., and Hittelman, W. N. p53 expressions: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 519-529, 1996
12. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992
13. Olshan, A. F., Weissler, M. C., Pei, H., and Conway, K. p53 mutations in head and neck cancer: New data and evaluation of mutational spectra. Cancer Epidemiol. Biomark. Prev., 6: 499-504, 1997
14. Sionov, R., and Haupt, Y. The cellular response to p53: the decision between life and death. Oncogene, 18: 6145-6157, 1999
15. Gasparini, G., Bevilacqua, P., Bonoldi, E., Testolin, A., Galassi, A., Verderio, P., Boracchi, P., Guglielmi, R., and Pezzella, F. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Clin. Cancer Res., 1: 1375-1383, 1995
16. Hirvikoski, P., Kumpulainen, E., Virtaniemi, J., Johansson, R., Haapasalo, H., Marin, S., and Halonen, P. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J. Clin. Oncol., 15: 3111-3120, 1997
17. Sauter, E., Ridge, J., Gordon, J., and Eisenberg, B. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am. J. Surg., 164: 651-653, 1992
18. Field, J., Malliri, A., Butt, S., Gosney, J., Phillips, D., Spandidos, D., and Jones, A. p53 expression in end stage squamous cell carcinoma of the head and neck prior to chemotherapy treatment: Expression correlates with a very poor outcome. Int. J. Oncol., 3: 431-435, 1993
19. Sauter, E., Ridge, J., Litwin, S., and Langer, C. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer. Clin. Cancer Res., 1: 1407-1412, 1995
20. Kaur, J., Srivastava, A., and Ralhan, R. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis. Int. J. Cancer, 79: 370-375, 1998
21. Rowley, H., Roland, N., Helliwell, T., Caslin, A., Kinsella, A., and Jones, A. p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin. Otolaryngol., 23: 57-62, 1998
22. Chiang, C., Huang, J., Wang, J., Liu, B., Kuo, Y., Hahn, L., and Kuo, M. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J. Oral Pathol. Med., 28: 72-76, 1999
23. Narayana, A., Vaughan, A., Gunaratne, S., Kathuria, S., Walter, S., and Reddy, S. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer (Phila.), 82: 286-291, 1998
24. Raybaud-Diogene, H., Fortin, A., Morency, R., Roy, J., Moteil, R., and Tetu, B. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study. J. Clin. Oncol., 15: 1030-1038, 1997
25. WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer (Phila.), 82: 2159-2165, 1998
26. Michalides, R. J., van Veelen, N. M., Kristel, P. M., Hart, A. A., Loftus, B. M., Hilgers, F. J., and Balm, A. J. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 497-502, 1997
27. Caminero, M., Nunez, F., Suarez, C., Ablanedo, P., Riera, J., and Dominguez, F. Detection of p53 protein in oropharyngeal carcinoma. Arch. Otolaryngol. Head Neck Surg., 122: 769-772, 1996
28. Bradford, C., Zhu, S., Wolf, G., Poore, J., Fisher, S., Beals, T., McClatchey, K., and Carey, T. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol. Head Neck Surg., 113: 408-412, 1995
29. Ito, T., Fujieda, S., Tsuzuki, H., Sunga, H., Fan, G., Sugimoto, C., Fukuda, M., and Saito, H. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett., 140: 81-91, 1999
30. Grabenbauer, G., Muhlfriedel, C., Rodel, F., Niedobitek, G., Hornung, J., Rodel, C., Martus, P., Iro, H., Kirchner, T., Steininger, H., Sauer, R., Weidenbecher, M., and Distel, L. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiation. Int. J. Radiat. Oncol. Biol. Phys., 48: 1041-1050, 2000
31. Frank, J., Bur, M., Garb, J., Kay, S., Ware, J., Sismanis, A., and Neifeld, J. p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer (Phila.), 73: 181-186, 1994
32. Dolcetti, R., Doglioni, C., Maestro, R., Gasparotto, D., Barzan, L., Pastore, A., Romanelli, M., and Boiocchi, M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications. Int. J. Cancer, 52: 178-182, 1992
33. Dursun, G., Sak, S., Akyol, G., Dursun, A., Erekul, S., Demireller, A., and Akiner, M. Overexpression of p53 in laryngeal carcinoma: clinicopathological implications. Ear Nose Throat J., 74: 645-648, 1995
34. Mineta, H., Borg, A., Dictor, M., Wahlberg, P., Akervall, J., and Wennerberg, J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br. J. Cancer, 78: 1084-1090, 1998
35. Taylor, D., Koch, W., Zahurak, M., Shah, K., Sidransky, D., and Westra, W. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: Correlation with p53 gene alterations. Hum. Pathol., 30: 1221-1225, 1999
36. Saunders, M., MacKenzie, R., Shipman, R., Fransen, E., Gilbert, R., and Jordan, R. Patterns of p53 gene mutations in head and neck cancer: Full-length gene sequencing and results of primary therapy. Clin. Cancer Res., 5: 2455-2463, 1999
37. Pai, H., Rochon, L., Clark, B., Black, M., and Shenouda, G. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 41: 37-42, 1998
38. Kokoska, M., Piccirillo, J., El-Mofty, S., Emami, B., Haughey, B., and Scholnick, S. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer (Phila.), 78: 1693-1700, 1996
39. Wilson, G., Richman, P., Dische, S., Saunders, M., Robinson, B., Daley, F., and Ross, D. p53 status of head and neck cancer: Relation to biological characteristics and outcome of radiotherapy. Br. J. Cancer, 71: 1248-1252, 1995
40. Pruneri, G., Pignataro, L., Carboni, N., Ronchetti, D., Cesana, B., Ottaviani, A., Neri, A., and Buffa, R. Clinical relevance of p53 and bcl-2 protein overexpression in laryngeal squamous-cell carcinoma. Int. J. Cancer, 79: 263-268, 1998
41. Koch, W. M., Brennan, J. A., Zahurak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, G. H., Lee, D. J., Forastiere, A. A., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 1580-1586, 1996
42. Bradford, C., Zhu, S., Poore, J., Fisher, S., Beals, S., Beals, T., and Thoraval, D. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Arch. Otolaryngol Head Neck Surg., 123: 605-609, 1997
43. Wright, D., and Manos, M. PCR Protocols: A Guide to Methods and Applications, pp. 153-158. San Diego: Academic Press, Inc, 1990
44. Olshan, A. F., Weissler, M. C., Pei, H., Conway, K., Anderson, S., Fried, D. B., and Yarbrough, W. G. Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, PRAD-1 and HPV. Oncogene, 14: 811-818, 1997
45. Kropveld, A. Slootweg, P., van Mansfeld, A., Blankenstein, M., and Hordijk, G. Radioresistence and p53 status of T2 laryngeal carcinoma: Analysis by immunohistochemistry and denaturing gradient gel electrophoresis. Cancer (Phila.), 78: 991-997, 1996
46. Hilsenbeck, S., Ravdin, P., de Moor, C., Chamness, G., Osborne, C., and Clark, G. Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res. Treat., 52: 227-237, 1998
47. Lowe, S., Bodis, S., McClatchey, A., Remington, L., Ruley, H., and Fisher, D. p53 status and the efficacy of cancer therapy in vivo. Science (Wash. DC), 266: 807-810, 1994
48. Lee, J., and Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA, 90: 5742-5746, 1993
49. Quon, H., Liu, F., and Cummings, B. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck, 23: 147-159, 2001
50. Otterson, G., Krazke, R., Coxan, A., Kim, Y., and Kaye, F. Abscence of p16 INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994
51. INK4A expression in human breast cancer. Am. J. Pathol., 149: 15-20, 1996
52. Hussussian, C., Struewing, J., Goldstein, A., Higgins, P., Ally, D., Sheahan, M., Clark, W., Tucker, M., and Dracopoli, N. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994
53. Caldas, C., Hahn, S., daCosta, L., Redston, M., Schutte, M., Seymore, A., Weinstein, C., Hruban, R., Yeo, C., and Kern, S. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994
54. Schmidt, E., Ichimura, K., Reifenberger, G., and Collins, V. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994
55. Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., and Holmberg, L. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl. Cancer Inst. (Bethesda), 88: 173-182, 1996
56. Gillison, M., Koch, W., and Shah, K. Human papillomavirus in head and neck squamous cell carcinoma: Are some head and neck cancers a sexually transmitted disease? Curr. Opin. Oncol., 11: 191-199, 1999
57. Gillison, M., Koch, W., Capone, R., Spafford, M., Westra, W. Wu, L., Zahurak, M., Daniel, R., Viglione, M., Symer, D., Shah, K., and Sidransky, D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. (Bethesda), 92: 709-720, 2000
58. Reid, B., Alberg, A., Klassen, A., Samet, J., Rozier, R., Garcia, I., and Winn, D. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer (Phila.), 92: 2109-2116, 2001
59. Ross, J., Stagliano, N., Donovan, M., Breitbart, R., and Ginsburg, G. Atherosclerosis and cancer: Common molecular pathways of disease development and progression. Ann. N. Y. Acad. Sci., 947: 271-292. 2001
60. Rothman, K., and Greenland, S. Modern Epidemiology, Ed. 2. Lippincott-Raven, 1-737, 1998